CytomX Therapeutics (CTMX) Return on Capital Employed [ROCE] (2015 - 2026)
CytomX Therapeutics (CTMX) recorded Return on Capital Employed [ROCE] of -26.38% in Q2 2026, down 70.58 percentage points from 44.21% a year earlier but up 2.82 percentage points from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2025, CytomX Therapeutics reported Return on Capital Employed [ROCE] of -25.01%, down 58.16 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a five-year change of +3.57 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at 33.15% in FY2024 (+41.75 pp), -8.60% in FY2023 (+60.09 pp), -68.68% in FY2022 (-25.89 pp) and -42.79% in FY2021 (-14.22 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -111.25% in Q4 2022 to 60.62% in Q1 2025 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -8.18 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 99.87 percentage points in Q1 2024, against a drop of 89.82 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -29.20% (Q1 2026), -20.65% (Q4 2025) and 18.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | CytomX Therapeutics | 573.08 Mn | -384.59 Mn | - | -26.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.38% |
| Mar 31, 2026 | -29.20% |
| Dec 31, 2025 | -20.65% |
| Sep 30, 2025 | 18.50% |
| Jun 30, 2025 | 44.21% |
| Mar 31, 2025 | 60.62% |
| Dec 31, 2024 | 56.83% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | 19.67% |
| Mar 31, 2024 | 22.23% |
| Dec 31, 2023 | -11.67% |
| Sep 30, 2023 | -22.50% |
| Jun 30, 2023 | -59.88% |
| Mar 31, 2023 | -77.64% |
| Dec 31, 2022 | -111.25% |
| Sep 30, 2022 | -105.92% |
| Jun 30, 2022 | -69.67% |
| Mar 31, 2022 | -54.05% |
| Dec 31, 2021 | -41.82% |
| Sep 30, 2021 | -32.95% |
API Access
CytomX Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();